Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-18-021551
Filing Date
2018-03-23
Accepted
2018-03-23 18:33:11
Documents
1
Period of Report
2018-03-21

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 10102
  Complete submission text file 0001209191-18-021551.txt   11500
Mailing Address
Business Address
SANDELL SCOTT D (Reporting) CIK: 0001237289 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37368 | Film No.: 18711336

Mailing Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX
Business Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX 44 1235 430000
Adaptimmune Therapeutics PLC (Issuer) CIK: 0001621227 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)